Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren J Strittmatter

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neurobiology of Aging|October 20, 2006
Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR miceCristina Osorio, Patrick M Sullivan, Dong Ning He, et al.
Journal of Lipid Research|May 20, 2003
ApoE genotype-specific inhibition of apoptosisRobert M DeKroon, Mirta Mihovilovic, Zoe V Goodger, et al.
Nature Neuroscience|June 29, 2002
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesAlexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, et al.
Journal of Amino Acids|February 8, 2012
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative DiseasesH Akiko Popiel, James R Burke, Warren J Strittmatter, et al.
Biochemical and Biophysical Research Communications|April 20, 2004
Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicityHelena A Popiel, Yoshitaka Nagai, Osamu Onodera, et al.
Human Molecular Genetics|May 23, 2003
Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in DrosophilaYoshitaka Nagai, Nobuhiro Fujikake, Katsuhito Ohno, et al.
Chemistry & Biology|September 23, 2008
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug librariesThung-S Lai, Yusha Liu, Tim Tucker, et al.
Journal of Neuroimmunology|January 27, 2004
APOE genotype-specific differences in human and mouse macrophage nitric oxide productionCarol A Colton, Leila K Needham, Candice Brown, et al.
Circulation Research|September 16, 2006
APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2Robert DeKroon, Jennifer B Robinette, Anita B Hjelmeland, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2010
Genome-wide scan of copy number variation in late-onset Alzheimer's diseaseErin L Heinzen, Anna C Need, Kathleen M Hayden, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neurobiology of Aging|October 20, 2006
Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR miceCristina Osorio, Patrick M Sullivan, Dong Ning He, et al.
Journal of Lipid Research|May 20, 2003
ApoE genotype-specific inhibition of apoptosisRobert M DeKroon, Mirta Mihovilovic, Zoe V Goodger, et al.
Nature Neuroscience|June 29, 2002
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesAlexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, et al.
Journal of Amino Acids|February 8, 2012
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative DiseasesH Akiko Popiel, James R Burke, Warren J Strittmatter, et al.
Biochemical and Biophysical Research Communications|April 20, 2004
Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicityHelena A Popiel, Yoshitaka Nagai, Osamu Onodera, et al.
Human Molecular Genetics|May 23, 2003
Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in DrosophilaYoshitaka Nagai, Nobuhiro Fujikake, Katsuhito Ohno, et al.
Chemistry & Biology|September 23, 2008
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug librariesThung-S Lai, Yusha Liu, Tim Tucker, et al.
Journal of Neuroimmunology|January 27, 2004
APOE genotype-specific differences in human and mouse macrophage nitric oxide productionCarol A Colton, Leila K Needham, Candice Brown, et al.
Circulation Research|September 16, 2006
APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2Robert DeKroon, Jennifer B Robinette, Anita B Hjelmeland, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2010
Genome-wide scan of copy number variation in late-onset Alzheimer's diseaseErin L Heinzen, Anna C Need, Kathleen M Hayden, et al.
Pageof 3